Article Type

1 - 15 of 64 Results       Clear All

UCSF Awarded $67.5 Million to Develop New Antiviral Therapies

Gladstone in the News May 18, 2022

UCSF Awarded $67.5 Million to Develop New Antiviral Therapies

UCSF News—Nevan Krogan, PhD, a senior investigator at Gladstone and the director of the Quantitative Biosciences Institute at UC San Francisco, leads a vast, international collaborative effort to find drugs against COVID-19 called the QBI Coronavirus Research Group (QCRG). The group recently received $67.5 million from the National Institutes of Health, the largest such award in UCSF's history, to pursue work on coronaviruses and other viruses with pandemic potential.

Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab

How Severe Is Omicron? Expert Says Variant’s 50 Mutations Could Be Its Downfall

Gladstone in the News December 8, 2021

How Severe Is Omicron? Expert Says Variant’s 50 Mutations Could Be Its Downfall

abc7 News—Senior Investigators Warner Greene, MD, PhD, and Nevan Krogan, PhD, discuss the possibility that Omicron, although more transmissible than previous SARS-CoV-2 variants, may cause less severe disease.

Gladstone Experts COVID-19 Center for HIV Cure Research Data Science and Biotechnology Virology Greene Lab Krogan Lab

Experts Peg Omicron as “Worst Variant That We Have Come Across”; Here’s What They Know So Far

Gladstone in the News November 26, 2021

Experts Peg Omicron as “Worst Variant That We Have Come Across”; Here’s What They Know So Far

ABC News—A new variant of SARS-CoV-2, dubbed Omicron, is causing concern around the world. Gladstone President Deepak Srivastava explains that some of the variant’s 50 mutations may have arisen when an individual who was already immunocompromised became infected with the virus. Senior Investigator Nevan Krogan describes how his group is investigating whether the new mutations will change the ability of the virus to enter cells and cause disease.

Gladstone Experts COVID-19 Data Science and Biotechnology Virology Krogan Lab Srivastava Lab

CRISPR Screening Identifies Human Host Pathways That Facilitate Coronavirus Infection

Gladstone in the News September 26, 2020

CRISPR Screening Identifies Human Host Pathways That Facilitate Coronavirus Infection

Life Science—The online science news hub Life Sciences highlights recent work from Senior Investigators Melanie Ott, MD, PhD, and Nevan Krogan, PhD, and their colleagues at BioHub and Synthego Corporation. The work describes the identification of host factors common to three coronaviruses including SARS-CoV-2, and could help bootstrap efforts to stem current and future coronavirus epidemics.

Gladstone Experts COVID-19 Data Science and Biotechnology Virology Krogan Lab Ott Lab CRISPR/Gene Editing

With Coronavirus Antibodies Fading Fast, Vaccine Hopes Fade Too

Gladstone in the News July 16, 2020

With Coronavirus Antibodies Fading Fast, Vaccine Hopes Fade Too

San Francisco Chronicle—Commenting on the disappointing recent reports about antibodies as barriers against coronavirus infection, Senior Investigator Nevan Krogan, PhD, and Visiting Scientist Danielle Swaney, PhD, emphasize the need for drug treatments as an alternative, and describe how they look for such treatments.

Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab

More News

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media